1. Home
  2. ICFI vs MNKD Comparison

ICFI vs MNKD Comparison

Compare ICFI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$89.73

Market Cap

1.3B

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$4.17

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
MNKD
Founded
1969
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
ICFI
MNKD
Price
$89.73
$4.17
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$99.25
$8.69
AVG Volume (30 Days)
207.7K
4.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
2.61
N/A
Revenue
$1,229,162,000.00
$348,966,000.00
Revenue This Year
$4.12
$35.81
Revenue Next Year
$5.33
$11.89
P/E Ratio
$34.13
N/A
Revenue Growth
3.72
22.23
52 Week Low
$58.83
$2.23
52 Week High
$101.50
$6.51

Technical Indicators

Market Signals
Indicator
ICFI
MNKD
Relative Strength Index (RSI) 60.23 56.27
Support Level $84.28 $3.74
Resistance Level $89.91 $4.55
Average True Range (ATR) 3.34 0.21
MACD -0.31 0.04
Stochastic Oscillator 53.91 77.92

Price Performance

Historical Comparison
ICFI
MNKD

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: